52 Week's Low
Returns % | |
1 Month Return | + 21.28 % |
3 Month Return | + 21.28 % |
1 Year Return | + 21.28 % |
Market Stats | |
Previous Close | ₹7.98 |
Open | ₹8.37 |
Volume | 700.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹4.18Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹292.81 Cr |
P/B Ratio | 2.06 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 12.76 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹292.81 Cr | 121.14% | 0.54 | NA | NA | |
NA | ₹1,758.34 Cr | 519.15% | 0.52 | NA | NA | |
NA | ₹0.00 Cr | -5.07% | 0.58 | NA | NA | |
NA | ₹55.35 Cr | 8.46% | 0.78 | ₹2 Cr | ₹45 Cr | |
NA | ₹2,176.83 Cr | 13.38% | 0.51 | NA | NA |
Organisation | Venmax Drugs & Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, Venmax Drugs stock has moved up by 21.3%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 76.72% of holdings in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 23.14% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 61.6% return, outperforming this stock by 40.3%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 23.14% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 76.72% | 0.00 | |
Others | 0.15% | 0.00 |
Venmax Drugs & Pharmaceuticals Ltd’s net profit fell -900% since last year same period to ₹0.30Cr in the Q2 2024-2025. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated -3100% fall in its net profits since last 3-months.
Read More about Earnings ResultsVenmax Drugs & Pharmaceuticals Ltd (531015) share price today is ₹8.37
Venmax Drugs & Pharmaceuticals Ltd is not listed on NSE
Venmax Drugs & Pharmaceuticals Ltd is listed on BSE
Today’s traded volume of Venmax Drugs & Pharmaceuticals Ltd(531015) is 700.00.
Today’s market capitalisation of Venmax Drugs & Pharmaceuticals Ltd(531015) is ₹4.18Cr.
Venmax Drugs & Pharmaceuticals Ltd(531015 | Price |
---|---|
52 Week High | ₹8.37 |
52 Week Low | ₹6.27 |
Venmax Drugs & Pharmaceuticals Ltd(531015) share price is ₹8.37. It is down -0.00% from its 52 Week High price of ₹8.37
Venmax Drugs & Pharmaceuticals Ltd(531015) share price is ₹8.37. It is up 33.49% from its 52 Week Low price of ₹6.27
Venmax Drugs & Pharmaceuticals Ltd(531015 | Returns |
---|---|
1 Day Returns | 0.39% |
1 Month Returns | 21.28% |
3 Month Returns | 21.28% |
1 Year Returns | 21.28% |